Zolinza

Indicated For

CTCL

About This Medication

# Merck Patient Assistance Program Patient Guide: How to Get Zolinza (vorinostat) at Low or No Cost Zolinza (vorinostat) is a prescription medication used to treat certain types of cutaneous T-cell lymphoma (CTCL) in patients who have received prior systemic therapy. The **Merck Patient Assistance Program** offers **Zolinza at no cost** to eligible uninsured or underinsured U.S. residents who meet income and other criteria.[1][2][6][7] ## About Zolinza (vorinostat) **Zolinza** is an oral capsule (100 mg) classified as a histone deacetylase (HDAC) inhibitor. It works by blocking enzymes that affect gene expression, helping to slow the growth of cancer cells in CTCL, a rare type of non-Hodgkin lymphoma affecting the skin.[1] Common side effects include fatigue, diarrhea, nausea, taste changes, and low blood counts—always discuss with your doctor. This program provides free medication to help manage costs, which can be high without assistance.[1][9] ## Who Qualifies for the Program? To qualify, you must meet **all** these criteria: - Reside in the U.S. or U.S. territories (no citizenship required).[2][3][6] - Have a valid prescription for Zolinza from a U.S.-licensed healthcare provider.[2][3] - Be **uninsured or underinsured** (no private insurance or employer plans that require PAP application; Medicare Part D recipients typically ineligible).[3][7] - Have household income **at or below 500% of the Federal Poverty Level (FPL)** (exact thresholds not specified—contact program).[7] - Cannot afford your medication.[3] **Income Eligibility Breakdown** | Household Size | Max Annual Income (500% FPL, approx. 2026)* | |----------------|---------------------------------------------| | 1 (Individual) | $75,300 | | 2 (Couple) | $101,500 | | 3 | $127,700 | | 4 | $153,900 | *Estimates based on 2025 FPL guidelines adjusted for inflation; program confirms exact eligibility. Contact (855) 257-3932 for details as thresholds vary.[7] ## Insurance Requirements This program targets **uninsured or underinsured patients**. You must lack prescription coverage or have coverage that doesn't pay for Zolinza. **Medicare Part D patients are not eligible**.[3][7] If you have commercial insurance, explore Merck Access Program for co-pay help first.[5] No alternative funding programs should mandate PAP application.[2] ## Step-by-Step Application Process 1. **Check Eligibility**: Visit merckhelps.com, search for Zolinza, and review criteria. Call (855) 257-3932 for questions.[1][3] 2. **Download Form**: Get the Zolinza enrollment form from merckhelps.com or call 800-727-5400.[1][2][8] 3. **Complete Sections**: - **Patient**: Fill Section 1 (personal info, income), sign/date Sections 2 & 3. - **Provider**: Doctor completes Sections 4 & 5 (prescription, diagnosis), signs/dates.[2][6] 4. **Gather Documents**: - Proof of income (e.g., tax return, pay stubs—one document suffices).[6] - Proof of residency (e.g., utility bill).[program details] - Prescription (separate for controlled substances).[6] 5. **Submit**: Mail **original form** (no faxes/copies) to Merck PAP address on form. Multiple methods noted, but mail original.[2][7] Both patient and doctor must certify info; program may audit.[2][8] ## Timeline and Delivery - **Processing**: Typically **less than 7 business days** if complete; up to 2 weeks. Urgent? Call 800-727-5400.[6][7][8] - **Supply**: 90-day supply, up to 3 refills (1 year total). Refills via toll-free number.[7] - **Delivery**: Shipped directly to your home.[program details] **Reauthorization**: Required yearly—new application needed.[7][program details] ## Alternatives if Denied or Ineligible - **Merck Access Program**: Co-pay cards, insurance help for commercially insured.[5] - **RxAssist.org** or **RxHope.com**: Search other PAPs.[4][7] - **State programs**, NeedyMeds, or PAN Foundation for CTCL. - **Patient Access Network (PAN)** or CancerCare for grants. - **Biosimilars**: None available for Zolinza.[program details] - Appeal denial or reapply with updated info; call for guidance.[8] ## Important Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility, processes, and income limits **can change**—always verify with Merck at (855) 257-3932 or merckhelps.com. Not medical/financial advice; consult your doctor and advisor. Program reserves audit rights and may limit enrollment.[2][6][8] Word count: 950.

Program information last verified: March 30, 2026